1. |
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. DOI: 10.1016/S0140-6736(09)62124-3.
|
2. |
王颖, 江枫, 韩金栋, 等. 玻璃体腔硅油或C3F8填充对增生型糖尿病视网膜病变并发单纯玻璃体积血玻璃体切割手术疗效的影响[J]. 中华眼底病杂志, 2014, 30(2): 148-151. DOI: 10.3760/cma.j.issn.1005-1015.2014.02.008.Wang Y, Jiang F, Han JD, et al. Effects of vitrectomy combined with intraocular silicon oil or C3F8 tamponade on vitreous hemorrhage due to proliferative diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2014, 30(2): 148-151. DOI: 10.3760/cma.j.issn.1005-1015.2014.02.008.
|
3. |
American Diabetes Association. (2) Classification and diagnosis of diabetes[J]. Diabetes Care, 2015, 38 Suppl: S8-16. DOI: 10.2337/dc15-S005.
|
4. |
中华医学会眼科学分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.Chinese Ocular Fundus Diseases Society, Chinese Ophthalmological Society, Chinese Medical Association. Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China[J]. Chin J Ophthalmol, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.
|
5. |
Wakabayashi Y, Usui Y, Tsubota K, et al. Persistent overproduction of intraocular Vascular Endothelial Growth Factor as a cause of late vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy[J]. Retina, 2017, 37(12): 2317-2325. DOI: 10.1097/IAE.0000000000001490.
|
6. |
West JF, Gregor ZJ. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy[J]. Br J Ophthalmol, 2000, 84(8): 822-825. DOI: 10.1136/bjo.84.8.822.
|
7. |
Yorston D, Wickham L, Benson S, et al. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2008, 92(3): 365-368. DOI: 10.1136/bjo.2007.124495.
|
8. |
Sato T, Tsuboi K, Nakashima H, et al. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy[J]. Graefe’s Arch Clin Exp Ophthalmol, 2017, 255(4): 665-671. DOI: 10.1007/s00417-016-3522-8.
|
9. |
Lee BJ, Yu HG. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy[J]. Retina, 2010, 30(10): 1671-1677. DOI: 10.1097/IAE.0b013e3181dcfb79.
|
10. |
戴荣平, 董方田, 霍冬梅, 等. 糖尿病视网膜病变玻璃体切割手术后玻璃体积血的临床分析[J]. 中华眼底病杂志, 2007, 23(4): 241-243.Dai RP, Dong FT, Huo DM, et al. Clinical analysis of vitreous hemorrhage after vitrectomy in diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2007, 23(4): 241-243.
|
11. |
Shen YD, Yang CM. Extended silicone oil tamponade in primary vitrectomy for complex retinal detachment in proliferative diabetic retinopathy: a long-term follow-up study[J]. Eur J Ophthalmol, 2007, 17(6): 954-960. DOI: 10.1177/112067210701700614.
|
12. |
Cardoso CRL, Leite NC, Dib E, et al. Predictors of development and progression of retinopathy in patients with type 2 diabetes: importance of blood pressure parameters[J/OL]. Sci Rep, 2017, 7(1): 4867[2017-07-07].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501788/pdf/41598_2017_Article_5159.pdf. DOI: 10.1038/s41598-017-05159-6.
|
13. |
Zhao XY, Xia S, Chen YX. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials[J]. Br J Ophthalmol, 2018, 102(8): 1077-1085. DOI: 10.1136/bjophthalmol-2017-311344.
|
14. |
孙刚, 黄冠华, 王丛, 等. 高血压合并2型糖尿病患者的动脉弹性与内皮功能[J]. 中华高血压杂志, 2007, 15(10): 835-838. DOI: 10.3969/j.issn.1673-7245.2007.10.012.Sun G, Huang GH, Wang C, et al. Arterial function in patients with hypertension co-existed with type 2 diabetes mellitus[J]. Chin J Hypertension, 2007, 15(10): 835-838. DOI: 10.3969/j.issn.1673-7245.2007.10.012.
|